Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.
Agrawal et al. • 2011 • Mol Pharmacol. 2011;80(3):389-99.
© 2024 Corcept Therapeutics, Incorporated
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile.
Hunt et al. • 2015 • Bioorg Med Chem Lett. 2015;25(24):5720-5.
Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486).
van der Lely et al. • 1991 • Ann Intern Med. 1991;114(2):143-4.
Antiglucocorticoid therapy for older adults with anxiety and co-occurring cognitive dysfunction: results from a pilot study with mifepristone.
Lenze et al. • 2014 • Int J Geriatr Psychiatry. 2014;29(9):962-9.
Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator.
Zalachoras et al. • 2013 • Proc Natl Acad Sci U S A. 2013;110(19):7910-7915.
The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test.
Solomon et al. • 2014 • Horm Behav. 2014;65(4):363-71.
A mixed glucocorticoid/mineralocorticoid receptor modulator dampens endocrine and hippocampal stress responsivity in male rats.
Nguyen et al. • 2017 • Physiol Behav. 2017;178:82-92.
Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area.
Butts KA, Phillips AG. • 2013 • Int J Neuropsychopharmacol. 2013;16(8):1799-807.
A randomized phase I trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel, Abraxane®) with or without mifepristone for advanced breast cancer
Nanda et al. • 2013 • Cancer Res 2013;73(24 Suppl): Abstract nr P2-16-21.
Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer.
Baker et al. • 2015 • Cancer Manag Res. 2015;7:361-8.